Investigating the impact of aspartame on Alzheimer’s disease through network toxicology and molecular docking
Frontiers in Nutrition · 09.01.2026 · 12
DOI: 10.3389/fnut.2025.1733469 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 09.01.2026. Verfasst von Lili Ge und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, The Second Qilu Hospital of Shandong University, Jinan, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Introduction
Alzheimer’s disease (AD) is a prevalent neurodegenerative disorder, and the relationship between its pathogenesis and environmental factors has garnered increasing scholarly interest. Aspartame, a widely utilized artificial sweetener, has potential neurotoxic effects that remain incompletely understood. This study employs network toxicology and molecular docking to speculate on the potential molecular mechanisms by which aspartame is involved in the pathological process of AD.
Methods
By integrating data from multiple databases, including ChEMBL, SwissTargetPrediction, OMIM, and GeneCards, we obtained the shared targets of aspartame and AD. A protein–protein interaction (PPI) network was constructed using the STRING database and Cytoscape software to discern the core targets. Subsequently, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed via the DAVID database, and molecular docking validation of the core targets was conducted using AutoDock Vina.
Results
In this study, a total of 298 targets associated with aspartame and 2,042 targets related to AD were identified. Seventy-five common targets were discovered, with BCL2, PPARG, TNF, IL1β, MAPK3, ESR1, and CASP3 were hypothesized as key core targets. GO functional analysis indicated that these targets are predominantly involved in biological processes such as protein metabolism, neuroinflammation, apoptosis, and oxidative stress. Furthermore, KEGG pathway analysis revealed significant enrichment in pathways TNF signaling, MAPK signaling, and PI3K-Akt signaling, among others. Molecular docking studies have shown that aspartame has A certain binding affinity with some core targets.
Discussion
It is speculated that aspartame may be involved in the key pathological processes of AD through multi-target and multi-pathway mechanisms, including neuroinflammation, apoptosis and amyloid-beta (Aβ) metabolism. This computational study speculates that aspartame, as an environmental exposure factor, is involved in the potential molecular mechanism of AD pathogenesis, thereby providing a theoretical basis for evaluating its neurotoxicity. Further experimental studies are needed in the future to confirm its biological effects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Traditional Chinese Medicine, The Second Qilu Hospital of Shandong University, Jinan, China.
- Department of Neurology, The Second Qilu Hospital of Shandong University, Jinan, China.
- Department of Pharmacy, Shanghe County People's Hospital, Jinan, China.
Zitieren
APA
Ge, L., Sun, H., Zhang, J., Xu, L., Ma, L., & Jin, Z. (2026). Investigating the impact of aspartame on Alzheimer’s disease through network toxicology and molecular docking. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1733469
Vancouver
Ge L, Sun H, Zhang J, Xu L, Ma L, Jin Z. Investigating the impact of aspartame on Alzheimer’s disease through network toxicology and molecular docking. Frontiers in Nutrition. 2026;12. doi:10.3389/fnut.2025.1733469
BibTeX
@article{Ge2026,
author = {Ge, Lili and Sun, Haitao and Zhang, Jianxin and Xu, Linlin and Ma, Lei and Jin, Zhi},
title = {Investigating the impact of aspartame on Alzheimer’s disease through network toxicology and molecular docking},
journal = {Frontiers in Nutrition},
year = {2026},
volume = {12},
doi = {10.3389/fnut.2025.1733469}
}
EUVIMED